People living with epilepsy can now keep a diary of their seizures on their iPhone, thanks to the new "My Epilepsy Diary" iPhone app. The app is made available in part by the Epilepsy Therapy Project Clinical Organizer, an integrated suite of consumer health tools and information that offers the app free on www.Epliepsy.com. It can now also be found on the iPhone through the App Store by searching "epilepsy."
The U.S. Consumer Product Safety Commission, in cooperation with Black & Decker (U.S.) Inc., of Towson, Md., announced a voluntary recall of the Black & Decker Random Orbit Sanders because the black plastic disc (called the platen) that holds the sandpaper can fly off or break apart during use and the disc, or pieces of the disc, can hit the user or those nearby, posing a laceration hazard. Consumers should stop using recalled products immediately unless otherwise instructed.
Just days before Johnson & Johnson announced a voluntary recall of hip replacement parts the company received a warning letter from the U.S. Food & Drug Administration (FDA) about illegally marketing other joint replacement products. Both the recalled hip-replacement parts and the joint replacement products are manufactured and distributed by J&J's DePuy Orthopaedics Inc. subsidiary.
Switching from brand name Keppra to generic Keppra (levetiracetam) to treat her epileptic seizures made Tracy Michele sick. "When I was taking Keppra I was a little drowsy in the beginning, but then it went away after about three weeks," she wrote on Daily Strength's discussion board. "I was switched to generic and I now have bad headaches and sleep too much and even have anorexia." The 5-foot 7-inch woman tops the scales at 107 pounds but says all she sees when she looks in the mirror now is "a woman who is very overweight."
MONTGOMERY, ALA. (September 9, 2010) – Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. has filed a lawsuit on behalf of several cities for losses in revenue as a result of the oil disaster in the Gulf of Mexico. The suit is the first to be filed by cities that are not on the Gulf Coast but have suffered revenue losses. The suit is filed in the U.S. District Court of the Middle District of Alabama on behalf of Greenville, Evergreen, Georgiana, and McKenzie, Alabama, as they have had to weather a significant decrease in tourist traffic to the Gulf coast in their highest season. The suit alleges negligence, and damages under the Oil Pollution Act. Defendants named in the suit are BP, Transocean, Anadarko, Mitsui, Moex Offshore 2007, Halliburton, Cameron International, and M-I. Attorneys representing the Plaintiffs are Jere L. Beasley and Rhon Jones of Beasley Allen, as well as Richard Hartley of Hartley & Hickman.
A fully functional prototype of a wristwatch-style device that can detect myoclonic and grand mal seizures in the person wearing it and notify caregivers via cell phone or e-mail message within seconds is awaiting Food and Drug Administration (FDA) approval. The SmartWatch is produced by Smart Monitor, an entrepreneurial offshoot of video security company Intellivision. The company hopes that the watch will give peace of mind not only to epileptics but their caregivers as well.
The Insurance Institute for Highway Safety just released the results of tests on 72 models of child safety "booster" seats, designed to keep older children properly restrained in automobiles. The booster seats are the next step after a traditional car seat for infants and young children. Booster seats are generally produced for youngsters ages 4-8. Booster seats are designed to simply raise children to the proper height so that an automobile's standard safety belt will properly restrain them in the event of a crash.
Parents of children diagnosed with epilepsy have the daunting responsibility of helping their child maintain a healthy lifestyle and ensuring he or she has regular medical care. To help parents with this endeavor, the National Center for Project Access and the Epilepsy Foundation have released a new toolkit for parents of children newly diagnosed with epilepsy.
Johnson & Johnson was sued by a California construction worker over an implanted hip-replacement device that the drugmaker stopped selling last month after defect reports surfaced.
A Class 1 recall has been issued on certain types of Huber safety needles because they may produce "cores" when inserted into ports. These cords may lead to potentially fatal infection, damage or death of tissue, swelling or other serious health consequences as they travel through blood vessels into the patient's lungs.
